FindTrial
Sign In

Effect of neoadjuvant chemotherapy on postoperative cognitive dysfunction in breast cancer patients

Effect of neoadjuvant chemotherapy on postoperative cognitive dysfunction in breast cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044390
Enrollment
Unknown
Registered
2021-03-17
Start date
2021-03-17
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative cognitive dysfunction

Interventions

Case series:Nil

Sponsors

Guangxi Medical University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The American society of anesthesiologists (ASA) class I to III; (2) Aged 40 to 80 years old, no serious audio-visual impairment, reading ability; (3) No history of cardiovascular and brain related system diseases; (4) Radical mastectomy of breast cancer was planned under general anesthesia, and the operation time >=2 hours.

Exclusion criteria

Exclusion criteria: (1) Refuse to participate in this experiment; (2) End-stage breast cancer patients receiving endocrine therapy; (3) Patients who cannot complete the questionnaire due to language barrier; (4) patients with previous mental symptoms or diseases unable to cooperate, psychotropic drug dependence; (5) Patients with intracranial abnormalities examined by cranial CT or MRI.

Design outcomes

Primary

MeasureTime frame
cognitive function;—

Countries

China

Contacts

Public ContactFei Lin

Guangxi Medical University Cancer Hospital

flylin0208@163.com+86 18154617381

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026